FTC gearing up for aggressive oversight of antitrust, M&A

FTC

With a changing of the guard, the Federal Trade Commission is undergoing some major restructuring on the antitrust front. All told, it’s not just Big Tech and pharmaceutical companies that should be on alert.

WELCOME TO OUR OPEN HOUSE – LOG IN TO CONTINUE READING FOR FREE

If you are already a registered user or a member, SIGN IN now.